In a report released today, Luke Sergott from Barclays maintained a Buy rating on Revvity (RVTY – Research Report), with a price target of $135.00. The company’s shares closed last Friday at ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in Coral Gables ...

For research use only. Not for use in diagnostic procedures. At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions ...

同时放射性同位素检测仪器在核药开发过程中扮演着重要角色，Revvity放射性同位素检测仪器有着70年的技术积累，可以一站式解决您的问题。 图1 Revvity放射性同位素检测部分仪器 自1905年居里夫人使用镭针进行第一例放射性同位素插入治疗以来，核药经历了从 ...

Revvity (RVTY) announced it will host an investor day on Thursday, November 21 which will feature presentations by members of Revvity’s senior management team on the company’s key business ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT which will feature presentations by members ...

Revvity, Inc. (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT which will feature presentations by members of Revvity’s senior ...

Shares of Revvity Inc. RVTY slipped 5.63% to $109.52 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.32% to 5,870.62 and ...